A 48-year-old 
Introduction

Neuropsychiatric manifestations of systemic lupus erythematosus (NP-SLE) include organic brain syndrome (OBS), stroke syndrome, seizures, polyneuropathy or mononeuropathy, cranial neuropathy, psychiatric disorders, transverse myelitis, and intractable headache (1). OBS is defined by altered mental function with impaired orientation, memory, or other intellectual function (2). Delirium is a form of OBS and it is often observed in NP-SLE (3). NP-SLE is sometimes a critical condition, and both NP-SLE and its treatment carry a considerable (7% to 19%) mortality rate (4). In this report, we describe a patient with OBS as a manifestation of NP-SLE who was successfully treated with high -dose corticosteroids, plasma exchange, double-filtration plasmapheresis (DFPP), and intravenous cyclophosphamide.
In addition, concomitant lupus nephritis, myositis, and pericarditis resolved during treatment. With this patient, serial electroencephalograms (EEGs) precisely demonstrated the neurological condition and therapeutic efficacy, in contrast with serial assessment of protein levels in cerebrospinal fluid which did not appeared to parallel changes in the neurological condition.
Case Report
. Therefore, double-filtration plasmapheresis (DFPP) (3 L, replacement with 5% albumin) was performed on days 38, 41, and 45 (Fig. 1) . In addition, intravenous cyclophosphamide (700 mg, 400 mg/m 2 ) was given on day 39. Soon after the first DFPP treatment, memory dysfunction improved markedly (Fig. 1) . On day 51, F i g u r e 1 . (Fig. 2E) (Fig. 1) (Fig. 2F) (Fig. 1) .
Cl i n i c a l c o u r s e o f t h i s p a t i e n t . Ab b r e v i a t i o n s a r e a s f o l l o ws : AZ P , a z a t h i o p r i n e ; CS F , c e r e b r o s p i n a l f l u i d ; DF P P , d o u b l e -f i l t r a t i o n p l a s ma p h e r e s i s ; E E G, e l e c t r o e n c e p h a l o g r a m; I VCY, i n t r a v e n o u s c y c l o p h o s p h a mi d e ; mP S L , me t h y l -p r e d n i s o l o n e ; P E , p l a s ma e x c h a n g e ; P S L , p r e d n is o l o n e .
EEG findings revealed an almost normal basic rhythm (9 Hz waves)
. On day 82, a mild Pneumocystis carinii pneumonia developed and the beta-D glucan level increased to 113 pg/mL (normal range <20). Treatment with sulfamethoxazole-trimethoprim improved the pneumonia by day 90. The patient's intellectual function recovered gradually, and EEG examination was normal on day 97
Discussion
A diagnosis of NP-SLE is made not only by the presence of SLE with concomitant neurological disorders but also by exclusion of other possible etiologies such as infection, malignancy, hypertension, and metabolic disorders (7). Therefore, intensive investigations including CSF analysis, brain
imaging, and serological study are mandatory for diagnosis (7) . However, one review found that a series of CSF analysis was normal in 13 
Regarding EEG findings in the setting of NP-SLE, abnormalities closely relate to the clinical evidence of cerebral involvement with SLE (8). EEG findings can also indicate the response to treatment with corticosteroids (8). In addition, EEG findings may help to distinguish psychosis as a manifestation of NP-SLE from steroid psychosis (8). However, Colamussi et al reported only 60% of SLE patients with central nervous system (CNS) manifestations such as stroke, seizures, personality disorders, psychosis, cerebellar ataxia, and dementia, demonstrated abnormal EEG findings (9). Therefore, normal EEG findings may not exclude the presence of CNS lesions due to SLE. Recently, brain single photon emission computerized tomography (SPECT) has been introduced as a sensitive tool to detect brain abnormalities in patients with SLE (9, 10). However, EEG is more convenient compared with other tools such as MRI and SPECT, and EEGs should be performed for the primary investigation of OBS as a manifestation of NP-SLE.
When we consider the pathogenesis of NP-SLE, vasculitis (12, 13) . In addition, intrathecal treatment with methotrexate and dexamethasone is considered to be effective in some patients with refractory NP-SLE (7, 14 (17) . However, patients treated with plasma exchange have a significantly more rapid reduction of serum anti-ds DNA levels (17) . In patients with OBS as a manifestation of NP-SLE (such as our patient), cerebral function can deteriorate rapidly and can result in decerebrate rigidity that is a highly critical condition if effective treatment is not initiated (18) . Therefore, the speed of therapeutic effectiveness may be important in NP-SLE, and plasmapheresis may improve the clinical outcome as reported in an uncontrolled study. In the setting of Guillain-Barre syndrome (GBS), an autoimmune polyneuropathy caused by anti-ganglioside autoantibodies, the clinical improvement appears more quickly with plasma exchange than with DFPP (19) . In addition, the ability of plasma exchange to remove both IgG and antiganglioside IgG antibodies is significantly superior to that of DFPP (20) 
